Combined treatment with two drugs targeting different points in the same growth-factor pathway delayed the development of treatment resistance in patients with BRAF-positive metastatic malignant melanoma. The results of a ...
Sep 29, 2012
0
0
With the steady increase in the life expectancy of Europe's population, researchers estimate that the number of people affected by age-related diseases, such as Alzheimer's disease, will increase dramatically in the next ...
Sep 18, 2012
0
0
(Medical Xpress)—ImmuNext, founded by scientists at King's College London, has announced a  research and drug development agreement with Janssen Biotech Inc to develop a new cancer drug to trigger the body's own immune ...
Sep 10, 2012
0
1
The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference between prasugrel and clopidogrel in the ...
Aug 27, 2012
0
0
Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable ...
Jul 18, 2012
0
0
(Medical Xpress) -- Researchers at the University of California, Davis, have discovered a class of natural compounds found within the body that may someday lead to pain relief for millions of diabetics and others suffering ...
Jun 26, 2012
1
0
New research from psychologists at the Universities of Exeter and Cardiff shows that people can train their brains to become less impulsive, resulting in less risk-taking during gambling. The research could pave the way for ...
Jun 14, 2012
1
0
The human immune system has a natural ability to identify and attack tumor cells. Natural killer (NK) cells are innate immune cells that are particularly effective at killing tumor cells due to their ability to secrete cytotoxic ...
Jun 11, 2012
0
1
(Medical Xpress) -- A receptor recently discovered to control the movement of immune cells across central nervous system barriers (including the blood-brain barrier) may hold the key to treating multiple sclerosis (MS), a ...
Jun 11, 2012
0
0
Inhibition of pre-B Cell Colony-Enhancing Factor (PBEF) could be a potential therapeutic target for pulmonary hypertension (PH), according to a preclinical study in an animal model of PH.
May 22, 2012
0
0
